Table 4 Comparison of patient characteristic with and without abdominal organ recurrence
Abdominal organs ( +) (n = 33) | Abdominal organs (-) (n = 55) | p | |
|---|---|---|---|
Age (> 50), n (%) | 5 (15.2) | 21 (38.2) | 0.022 |
Histology (pure NECC), n (%) | 23 (69.7) | 39 (70.9) | 0.904 |
FIGO stage (III + IV), n (%) | 10 (33.3) | 19 (38.0) | 0.674 |
Tumor size (> 4 cm), n (%) | 7 (31.8) | 12 (31.5) | 0.985 |
Invasion (Deep), n (%) | 24 (80.0) | 33 (67.3) | 0.223 |
LVSI | 25 (92.6) | 30 (75%) | 0.129 |
Nerve invasion | 11 (50.0) | 10 (27.8) | 0.088 |
PLNM | 10 (33.3) | 19 (36.5) | 0.770 |
Adjuvant radiation | 22 (68.8) | 31 (60.8) | 0.462 |
Cycles of chemotherapy (≥ 4) | 27 (81.2) | 45 (83.3) | 0.856 |
Number of recurrent sites (> 1), n (%) | 19 (57.6) | 20 (36.4) | 0.052 |
Lung recurrence | 8 (24.2) | 26 (47.3) | 0.032 |
Pelvic organs recurrence | 8 (24.2) | 16 (29.1) | 0.621 |
Antiangiogenic therapy | 5 (17.9) | 9 (19.1) | 0.890 |
ICI therapy | 8 (28.6) | 14 (29.8) | 0.911 |